Innovation Project Funding Methods

Where to go when R&D funding dries up? *A LOT* of government funding for the sciences has been reappropriated or put on hold, and VCs don't like funding R&D. In my tech DD work, I've been fascinated by the creative ways some companies are raising R&D cash. Here are some interesting funding plays they are using: 1️⃣ Tokenized R&D (DeSci / DAO) - Issue governance or utility tokens so a global community bankrolls experiments and helps steer the roadmap. Example: VitaDAO pooled $4.1 M from token-holders to buy longevity IP-NFTs and license them back to researchers. 2️⃣ Crowdfunding 2.0 - Turn fans into shareholders or early customers with equity + reward tiers. Example: Kitchen-robot maker Miso Robotics raised $50M from over 18,000 retail investors on StartEngine (although the company has raised > $500 M from over 35,000 retail investors across several rounds, not exclusively through StartEngine). 3️⃣ Subscription “Discovery Clubs” - Members pay monthly for prototype drops, data dashboards, or private tastings. Example: Some cultivated meat companies advertise an insider waitlist for tours and preview dinners. 4️⃣ Advance Market Commitments (AMCs) - Secure a signed purchase promise before you finish the tech; cash releases on milestones. Example: Gavi, the Vaccine Alliance’s pneumococcal AMC unlocked rapid vaccine scale-up by guaranteeing future demand from 60 countries. 5️⃣ IP-Backed Credit Lines - Use patents or trade secrets as collateral for non-dilutive loans. Example: BlueIron IP structures $2-5 M facilities for startups against insured patent portfolios. 6️⃣ Royalty / Revenue-Share Financing - Investors take a slice of top-line until a cap is hit; cap table stays clean. Example: Meal-delivery brand Factor 75 used a Flow Capital royalty deal to fuel 10× growth before exiting to HelloFresh. 7️⃣ Venture Philanthropy - Impact-first funds blend grants with patient equity or recoverable loans. Example: The Gates Foundation’s Strategic Investment Fund backs drought-tolerant maize and other ag-tech targeting smallholders. 8️⃣ Venture Studios - Co-found alongside a studio that supplies labs, talent, and seed cash (for a bigger equity slice). Example: The Production Board incubated Cana - the molecular beverage printer - inside its food-and-ag studio (however, as of 2025, unfortunately, Cana didn't survive the current funding crisis). 9️⃣ A Donor-Advised Fund (DAF) is a charitable investment account that individuals, families, or organizations establish to support their philanthropic giving over time. Check out Jennifer Kan, PhD's post on this! What else have you seen that is helping to plug up the R&D funding gap? (Ha, maybe move to Europe, which just got a $350M infusion for biotech R&D? Or China - Who also dedicate a ton of government funding into biotech R&D?). Fig credit: Brian Buntz, R&D World - Might U.S. R&D spending crumple in 2025 and beyond? Likely not by much

"Waiting for Silicon Valley to fund your African start-up is like expecting Nairobi traffic to end because you prayed." In the face of limited VC access, the African start-up ecosystem continues to punch above its weight. But the truth is, most of us are building without a lifeline. While headlines celebrate the few start-ups that raise millions, thousands more struggle to get even $5,000 in seed funding. It doesn’t have to be this way. We don’t need to wait for "international investors" to see our potential. We can build alternative, culturally-grounded funding pools that move money to innovation faster, smarter, and with less bureaucracy. Here’s my thought: 1. Decentralized Chama Investment Funds Let’s take the sacred chama, the savings group that’s built homes, funded weddings, and paid school fees, and flip it into a micro VC syndicate. How it works: Small groups of professionals pool money monthly. Evaluate and vote on start-ups to fund. Returns can be reinvested or cashed out annually. Estimated Pool: $10,000–$50,000 per chama. 2. County-Based Start-up Trusts Why do counties only spend money on wheelbarrows and workshops? Each of Kenya’s 47 counties can set up a Startup Innovation Trust Fund to support local entrepreneurs solving county-specific problems. Example: Kisumu supports agri-tech & lake economy ventures. Mombasa invests in tourism-tech. Turkana backs water innovation start-ups. Funding sources: budget reallocations, diaspora bonds, and donor partnerships. 3. Diaspora Co-investment Platforms Kenyans abroad send back $4B+ annually, yet most can’t invest in local start-ups securely. Worse still conned of their hard-earned money. Let’s create regulated, secure platforms where diaspora can: Invest from $50 upwards in vetted start-ups. Track progress. Convert investments into equity or returns. 4. University Innovation Endowment Funds Instead of just graduating job seekers, let’s help universities graduate founders. Each major university creates an endowment fund: Alumni contribute. The government matches. Annual pitching competitions decide disbursements. Think Y-Combinator, but in Multimedia University of Kenya 5. Faith-Based Investment Pools Churches and mosques raise billions. Imagine allocating 5% of tithes to: Health tech. Ethical fintech. Youth-run innovation hubs. "Whatsoever you do for the least of these start-up founders…" 6. Barter-for-Equity Platforms Cash isn’t always king, sometimes, skills are. Let’s build platforms where: A lawyer drafts your IP documents for 1% equity. A dev codes your MVP in exchange for future stock. A designer brands your app for convertible notes. Want to Collaborate? I’m working on co-developing these models. Let’s build Chumvi Invest.

There are many funding options beyond raising equity capital (my career actually started in helping companies access non-dilutive funding). When I’m building the funding strategy for founders from scratch, we map out all their liquidity options (not just the obvious ones). Here’s what I’ve seen work for private companies at different stages: 1 - Periodic liquidity mechanisms. There are a few emerging platforms I’m excited about here, which are changing the game for private companies. They offer intermittent trading windows that let early investors and employees access liquidity without forcing an IPO or acquisition. This is massive for retention and cap table management. 2 - Revenue-based financing. For companies with strong recurring revenue, RBF provides capital without equity dilution. Repayments can also adjust to your sales topline, making cash flow management far less painful. 3 - Asset-based lending. If you’ve got inventory, receivables, or equipment on your balance sheet, you can unlock capital against those assets. I’ve seen a lot of founders use it for bridging funding rounds. 4 - Non-dilutive grants. Government programs (such as Innovate UK) and corporate innovation funds provide capital that doesn’t ask for any equity stake. Underutilised,and incredibly valuable for R&D-heavy businesses. Most popular at Pre Seed. 5 - Strategic debt/ venture debt. For companies that have already raised equity and need working capital without further dilution, venture debt can be a tactical bridge to the next milestone. Most often used at Series A & above. Mixing all of the above in addition to raising equity capital can build your solid funding journey from Pre Seed all the way to an IPO. #capitalraising #startupfunding #fundingoptions

Science commercialization is often framed as lab-to-market, but the real question is: who funds the “too applied for grants, too early for VC” zone? I've seen it firsthand: a chicken-and-egg problem where VCs want traction before they'll commit, and founders need capital to create the very traction investors demand. Too often, brilliant scientists with world-changing technologies get trapped here. How science founders can navigate this valley: 1. Build your funding stack based on alignment — Grants, philanthropy, corporate partnerships, and venture capital each comes with different north stars and risk tolerances. Understand how your science fits now and in the future and plan accordingly. 2. Approach expert funders — Seek out capital providers who deeply understand your space. They’re best positioned to see the potential and impact of your work before it’s consensus. 3. Stage-gate your milestones — Show a path where $X unlocks validation, $Y proves scale, and later capital accelerates commercialization. Make each milestone reduce one major risk for follow on funders. 4. Activate alternative capital — Donor-advised funds, venture philanthropy, mission-driven corporates, and government innovation programs can back early science that’s obvious to experts but not yet to markets. Use them to build incremental validation. 5. Design for optionality — Build multiple paths forward: non-profit arms for public good research, commercial spinouts for market applications, licensing deals for near-term revenue, and strategic partnerships for distribution. 6. Create urgency — Patent deadlines, grant reporting requirements, and pilot customer commitments can become forcing functions that accelerate decisions. Use them to your advantage in funding negotiations. What strategies have you used to bridge this valley? I'd love to hear examples that others can learn from, especially creative financing structures or unexpected funding sources that worked.

‼️ Everyone Wants SAF. No One Wants to Pay for It ‼️ So — How Do You Finance a £500M+ Clean Fuels Project⁉️ Let’s be blunt: SAF plants are not being built because of financing. High-CAPEX projects like SAF, e-fuels, methanol or hydrogen rarely die in the lab — They die in Pre-FEED, FEED or just before FID when the money actually needs to move. So let’s simplify the landscape. If you’re building a plant, here’s what your financing journey really looks like: 1. Pre-FEED / Pre-Development Stage Goal: Prove you’re credible enough to justify deeper due diligence. ✅ Typical funding sources: • Founder equity / angel capital — painful but essential skin in the game • Innovation grants (e.g. UK AFF, EU Innovation Fund, DOE in the US) • Strategic partnerships with tech licensors or feedstock suppliers (often in-kind support rather than cash) What works best? ➡️ Grants + early offtake LOIs — your only real credibility anchor at this stage. ⸻ 2. FEED / Advanced Development Stage Goal: Turn assumptions into engineering-grade numbers. ✅ Typical funding sources: • Blended public-private grant structures (e.g. matched funding) • Corporate venture capital (CVC) — but only if you’re aligned with their supply chain needs • Convertible debt from strategic partners (airlines, fuel suppliers) What works best? ➡️ Grants + CVC + strategic equity, but only if you can prove future revenue. ⸻ 3. FID / Construction Stage – The Real Cliff Edge Goal: Secure bankable contracts so lenders stop seeing you as “experimental.” ✅ Funding instruments that actually close deals: • Project finance (with senior debt + mezzanine) — only unlocked after offtake contracts & feedstock secured • Revenue Certainty Mechanisms (e.g. UK GSP, US 45Z, EU FEETS allowances) • Export Credit Agencies (ECAs) — massively underrated, especially for equipment-heavy builds • Loan guarantees from governments (e.g. US DOE LPO model) What works best? ➡️ Long-term offtake + GSP/45Z or similar policy-backed price floor. TL;DR — Here’s the Brutal Truth Technology without bankability is just a science project. Policy gives confidence. Offtakes give leverage. Guarantees unlock capital. If you’re stuck between FEED and FID and don’t know which lever to pull first — you’re not alone. That’s exactly the gap we help close at StratX: bridging strategy, partners and financing pathways so real plants actually get built. Let’s talk!

“EU startup funding is one of the best-kept secrets in early-stage innovation. Through massive programs like Horizon Europe and the EU Innovation Fund, the European Union is pouring billions into tech, sustainability, and research. And yet, only 5% of this funding goes to startups. That’s a missed opportunity. With just €12 billion in public funding, EU-backed startups have already created over €520B in enterprise value—without giving up a single share of equity. For founders, this is one of the most powerful ways to fundraise without VCs, scale internationally, and plug into top-tier research and partnerships. In this guide, we’ll break down: What EU Framework Programs offer Who qualifies—and how to apply How to use EU funding to supercharge your growth without diluting your ownership If you're building in Europe and not considering EU programs, you’re probably leaving money on the table. Let’s fix that!” https://lnkd.in/gVqCyifi

New German government on Venture Capital & Innovation. ⁉️ The expected new German government presented their government paper today, laying out the cornerstones for their upcoming term. I took a look at the document from a Venture Capital perspective, and it is clear that there is a strong and prominent focus on innovation and VC to invest in next German champions / tomorrow’s Mittelstand. Here are a few cornerstones (complete paper in the comments in German): 1️⃣ Economic Innovation Push: A clear commitment to innovative, future technologies such as AI, space, cybersecurity, and defense—envisioning Germany as an entrepreneurship country. In the paper, it’s even stated as “KI‑ and Gründer‑Nation.” 2️⃣ Improving Frameworks: A commitment to reducing bureaucracy for startups and investors through measures like a “Founder Sandbox,” simplification of notary processes, and the digitalization of procedures. There is also a clear focus on sponsoring female founders, addressing their underrepresentation in the ecosystem (Startup-Verband). 3️⃣ Germany Fund: This umbrella fund is designed to bridge existing funding gaps in growth and innovation capital, particularly for the Mittelstand and scale-ups, ensuring these sectors have the financial backing needed to thrive. The total expected size is EUR 100bn, of which EUR 10bn are government equity leveraged with additional guarantees. 4️⃣ WIN 2.0: With the goal of more than doubling investor commitments in the WIN initiative from the current EUR 12 billion to over EUR 25 billion, the government plans to activate further capital. The WIN initiative, managed by KfW is a great signal to the market and initiated by former minister Christian Lindner. 5️⃣ Overall Mobilization of Private Capital: By combining initiatives like WIN 2.0, changes under Solvency II (which lower the capital requirements for infrastructure projects and venture capital), and other measures, the government is paving the way for a broader mobilization of private capital. 👉🏼 It is great to see such a prominent and sizable commitment from the next German government towards innovation. Let’s keep our fingers crossed 🤞🏼 that the journey from plan to reality is a short one, Joerg What is your first impression? CDU Deutschlands Sozialdemokratische Partei Deutschlands (SPD) #germany #venturecapital BVK Bundesverband Beteiligungskapital Startup-Verband #assetmanagement

This marks an important step forward in how India supports innovation and it’s one I feel personally proud to be part of. I recently launched the first Open Call of the Research, Development & Innovation (RDI) Fund through the Technology Development Board (TDB). At its core, this initiative is about changing the way we finance technology in India especially when it comes to taking high-potential, high risk ideas from the lab to the market. Over the last 11 years, under the clear and consistent leadership of Shri Prime Minister Narendra Modi, India’s science and technology ecosystem has seen a fundamental shift. Sectors once considered out of bounds, like space, nuclear technologies and other strategic areas have been opened to private participation. Innovators, startups, and industry are no longer on the sidelines, they are central to our national development story. The ₹1 lakh crore RDI Fund, housed under the Anusandhan National Research Foundation (ANRF), reflects this evolution in thinking. It moves beyond traditional grant-based or CSR driven models and offers something far more enabling that is long-term, government backed financing that shares risk while demanding accountability. Through this first TDB window, we are supporting TRL 4 and above technologies with: • Funding of up to 50% of project cost • Collateral free loans, without personal or corporate guarantees • Concessional interest rates of 2-4% • Long tenures of up to 15 years, with moratorium provisions • A transparent, time bound evaluation and approval process What matters most to me is that this framework is designed not just to fund ideas, but to enable real world commercialisation, particularly in areas like AI, energy, and deep tech, where innovation is critical but financial risk is often a deterrent. The response to the first call has been extremely encouraging, with 191 proposals received, the majority from the private sector. This tells me that confidence in India’s innovation ecosystem is growing and that industry sees the government as a serious, reliable partner in technology led growth. Under Prime Minister Modi’s leadership, science and technology have become powerful drivers of entrepreneurship, jobs, and economic transformation. The RDI Fund is a natural extension of that vision. I encourage innovators, startups, industry leaders, and investors across the country to engage actively with this initiative. Together, we can strengthen India’s indigenous technological capabilities and take confident steps toward a truly Atmanirbhar Bharat.

There’s a growing misconception in the market that because the SBIR program is not currently active, federal innovation funding is “on hold.” That assumption is not just wrong, it’s risky. Here’s the reality: Participating agencies have already allocated their FY2026 SBIR set‑aside funds as part of their enacted funding bills. Those dollars are real, appropriated, and must be obligated by September 30, 2026 - only to small businesses. Agencies are not waiting idly. DOE is a clear signal of what’s happening across government. Through recent appropriations language, DOE has been given expanded flexibility to manage SBIR, STTR, and Technology Commercialization Fund (TCF) dollars within its R&D accounts. In plain terms: DOE can reprogram and deploy innovation funds, even while formal SBIR authorization remains stalled, so that critical R&D doesn’t sit on the sidelines. This is not a loophole. It’s a pressure valve. And DOE is not alone. NIH, DoD, and others are moving on parallel tracks. NIH has already shifted volume into Parent R01/R21 mechanisms and highlighted topics tied to its $48.7B FY26 budget. DoD is activating and expanding alternative pathways with substantial small‑business participation, including: ■ AFRL IDIQs ■ Army CSOs ■ DARPA office‑wide opportunities ■ Program‑specific BAAs and prototype vehicles These mechanisms can absorb SBIR‑like dollars, hit the same technical and commercialization milestones, and, critically,  allow agencies to meet their fiscal obligation deadlines. Here’s the key timing point many companies are missing: To obligate FY26 funds by September 30, agencies must open submission windows now, over the next 1–2 months, to allow time for: ■Proposal submission ■Technical and programmatic review ■Negotiation ■Contracting That process does not start in August. It must start now. Which means the window is opening, whether companies are ready or not. For small businesses, the takeaway is simple: Waiting for SBIR reauthorization as a single trigger is no longer a strategy. It’s a bottleneck. The agencies are moving. The money is allocated. The clock is running. At Eagle Point Funding, this is exactly where we operate best - helping companies position early, choose the right mechanisms, and move fast while others are still waiting for headlines. SBIRs will return. But FY26 funding is already in motion. The companies that win this year won’t be the ones who waited. #SBIR #dualusetech #GovCon

Federal innovation funding (SBIR/STTR) pending reauthorization is frozen. But a few lanes are still moving. SBIR and STTR are effectively stalled right now. Authority lapsed, budgets are stuck, solicitations are quiet. If you are waiting on a traditional cycle this quarter, you are waiting on politics. As I said previously I would hope something moves this month but there will still be a lag for those looking to submit which stretches out longer by the day. Of course we should keep an eye out for reauth but founders don't loose site that there is a live window open right now (among several). The Defense Innovation Unit Commercial Solutions Opening (CSO) backed by Department of Defense Other Transaction Authority is one of the federal pathways still accepting submissions and moving money. Why this matters right now: • CSOs are rolling. You submit against active Areas of Interest. • Selections can move to prototype awards in ~60–90 days. • OTAs are not FAR contracts. Terms are negotiable. Accounting is lighter. • Follow-on production is possible if you perform. • Commercial companies and non-traditional defense contractors are explicitly eligible. Translation: if you have real tech, real customers, and a real use case, this is not a science project. It is a procurement on-ramp. What teams get wrong: • Treating CSOs like SBIR white papers. They are not. • Over-engineering the submission instead of mapping directly to mission need. • No ROM cost clarity. No deployment path. No operator story. What works: • One clear problem. One clear solution. • Evidence your tech already works in the wild. • Be explicit on timeline, cost, and prototype scope. • Show how this transitions, not just how it pilots. Until SBIR and STTR reopen, this is one of the only federal capital lanes that is actually open for business. If you are a founder, operator, or investor working dual-use or defense-adjacent tech: are you leaning into CSOs right now, or sitting tight waiting for the old system to come back online? #DefenseInnovation #DualUse #GovTech #DoD #NationalSecurity